These findings highlight the possible role of FGF21 as a biomarker and a therapeutic tool in mice with sepsis and an inflammatory state, leading us to explore its role in humans with sepsis and systemic inflammatory response syndrome (SIRS) as compared with healthy subjects. Here, FGF21 is linked to Sepsis.